Across TCGA pan-cancer cohorts, OFD1P18Y RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated OFD1P18Y data layer.
The strongest signal is observed in glioblastoma multiforme (GBM), where higher OFD1P18Y RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OFD1P18Y expression acts as an unfavorable survival marker.
GBM are the cancer types where OFD1P18Y RNA most reproducibly stratifies survival.